Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Outlook Therapeutics Inc (OTLK)

1.2714   -0.009 (-0.67%) 08-07 15:04
Open: 1.28 Pre. Close: 1.28
High: 1.32 Low: 1.26
Volume: 1,432,805 Market Cap: 157M
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, a proprietary ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with MTTR, LLC; IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was founded in 2010 and is headquartered in Cranbury, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.343 - 1.35 1.35 - 1.355
Low: 1.242 - 1.251 1.251 - 1.258
Close: 1.268 - 1.281 1.281 - 1.292

Technical analysis

as of: 2020-08-07 2:29:10 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.81     One year: 2.02
Support: Support1: 1.25    Support2: 1.04
Resistance: Resistance1: 1.55    Resistance2: 1.73
Pivot: 1.42
Moving Average: MA(5): 1.32     MA(20): 1.43
MA(100):     MA(250): 1.11
MACD: MACD(12,26):     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 8.82     %D(3): 12.70
RSI: RSI(14): 42.24
52-week: High: 2.25  Low: 0.50  Change(%): -40.2
Average Vol(K): 3-Month: 316534  10-Days: 210435

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
OTLK has closed above bottom band by 14.1%. Bollinger Bands are 30.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 07 Aug 2020
Analysts provide insight on how high Outlook Therapeutics, Inc. (OTLK) can go - Stocks Register

Thu, 06 Aug 2020
Is Outlook Therapeutics, Inc. (OTLK) a Keeper? Bullish Price Target $9.00 - The News Heater

Wed, 05 Aug 2020
Is Now the Time to Invest in Outlook Therapeutics Inc. (NASDAQ:OTLK)? - The Oracle Dispatch

Wed, 29 Jul 2020
Has Outlook Therapeutics Inc (OTLK) Stock's Performance Changed Wall Street's View? - InvestorsObserver

Tue, 28 Jul 2020
Outlook Therapeutics Inc. (OTLK) is predicted to post EPS of -0.11 in the upcoming quarter : This Stock is Ticking Every Box for Top Investors - News Daemon

Fri, 24 Jul 2020
Outlook Therapeutics Inc. (OTLK) is on the roll with an average volume of 2.80M in the recent 3 months - The InvestChronicle

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqCM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 123
Shares Float (M) 41
% Held by Insiders
% Held by Institutions
Shares Short (K) 2,140
Shares Short P. Month (K) 2,150

Stock Financials

EPS -1.574
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -0.230
Profit Margin
Operating Margin -380.61
Return on Assets (ttm) -100.9
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.) -0.127
Sales Per Share 0.052
EBITDA (p.s.) -0.182
Qtrly Earnings Growth
Operating Cash Flow (M) -30
Levered Free Cash Flow (M) -19

Stock Valuations

PE Ratio -0.80
PEG Ratio
Price to Book value -5.51
Price to Sales 24.23
Price to Cash Flow -5.20

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.